Bayer Eyes Indications Beyond BlueRock's Initial Focus With $240m-Plus Buyout

 
• By Mandy Jackson
  
Business partners hands on top of each other symbolizing companionship
Bayer will oversee the company's operations, but maintain BlueRock's entrepreneurial nature. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business